Harel Insurance Investments & Financial Services Ltd. Gilead Sciences, Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$63.15 - $72.88 $3,599 - $4,154	-57 Reduced 8.89%	584 $40,000
Q4 2023 Jan 30, 2024	SELL	$73.27 - $83.09 $219 - $249	-3 Reduced 0.47%	641 $52,000
Q3 2023 Oct 30, 2023	SELL	$73.94 - $80.67 $1.3 Million - $1.42 Million	-17,634 Reduced 96.48%	644 $48,000
Q2 2023 Jul 17, 2023	SELL	$76.01 - $86.7 $1.09 Million - $1.25 Million	-14,402 Reduced 44.07%	18,278 $1.39 Million
Q1 2023 May 02, 2023	BUY	$77.31 - $88.08 $320,681 - $365,355	4,148 Added 14.54%	32,680 $2.66 Million
Q4 2022 Jan 26, 2023	BUY	$62.32 - $89.47 $456,930 - $655,994	7,332 Added 34.58%	28,532 $2.43 Million
Q3 2022 Oct 31, 2022	BUY	$59.54 - $68.01 $119,080 - $136,020	2,000 Added 10.42%	21,200 $1.34 Million
Q2 2022 Jul 19, 2022	BUY	$57.72 - $65.01 $1.1 Million - $1.24 Million	19,020 Added 10566.67%	19,200 $1.19 Million
Q1 2022 May 03, 2022	BUY	$57.92 - $72.58 $5,502 - $6,895	95 Added 111.76%	180 $11,000
Q4 2021 Feb 07, 2022	SELL	$64.88 - $73.64 $345,356 - $391,985	-5,323 Reduced 98.43%	85 $6,000
Q3 2021 Oct 25, 2021	BUY	$67.69 - $73.03 $172,067 - $185,642	2,542 Added 88.7%	5,408 $378,000
Q2 2021 Jul 26, 2021	SELL	$63.47 - $69.35 $82,384 - $90,016	-1,298 Reduced 31.17%	2,866 $643,000
Q1 2021 Apr 27, 2021	SELL	$60.0 - $68.46 $275,580 - $314,436	-4,593 Reduced 52.45%	4,164 $899,000
Q4 2020 Jan 26, 2021	SELL	$56.65 - $64.55 $452,803 - $515,948	-7,993 Reduced 47.72%	8,757 $1.64 Million
Q3 2020 Oct 20, 2020	BUY	$62.1 - $78.08 $965,406 - $1.21 Million	15,546 Added 1291.2%	16,750 $1.06 Million
Q2 2020 Jul 14, 2020	SELL	$72.34 - $84.0 $647,153 - $751,464	-8,946 Reduced 88.14%	1,204 $93,000
Q1 2020 Apr 28, 2020	BUY	$62.63 - $80.22 $632,938 - $810,703	10,106 Added 22968.18%	10,150 $759,000
Q4 2019 Jan 23, 2020	SELL	$61.62 - $67.78 $447,114 - $491,811	-7,256 Reduced 99.4%	44 $3,000
Q3 2019 Nov 06, 2019	BUY	$62.51 - $69.0 $181,279 - $200,100	2,900 Added 65.91%	7,300 $463,000
Q2 2019 Jul 22, 2019	BUY	$61.87 - $69.38 $74,244 - $83,256	1,200 Added 37.5%	4,400 $297,000
Q1 2019 Apr 18, 2019	SELL	$62.53 - $70.05 $50,899 - $57,020	-814 Reduced 20.28%	3,200 $208,000
Q4 2018 Jan 29, 2019	SELL	$60.54 - $79.0 $128,405 - $167,559	-2,121 Reduced 34.57%	4,014 $251,000
Q3 2018 Oct 29, 2018	SELL	$71.28 - $78.92 $560,617 - $620,705	-7,865 Reduced 56.18%	6,135 $474,000
Q2 2018 Jul 30, 2018	BUY	$64.88 - $75.68 $129,759 - $151,360	2,000 Added 16.67%	14,000 $992,000
Q1 2018 Apr 30, 2018	BUY	$72.84 - $88.8 $506,383 - $617,337	6,952 Added 137.72%	12,000 $905,000
Q4 2017 Feb 01, 2018	BUY	$71.15 - $83.52 $1,992 - $2,338	28 Added 0.56%	5,048 $362,000
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $361,992 - $429,059	5,020	5,020 $407,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account